Understanding arsenic carcinogenicity by the use of animal models.

[1]  M. Vahter,et al.  Reduction and binding of arsenate in marmoset monkeys , 1985, Archives of Toxicology.

[2]  S. Fukushima,et al.  Induction of glutathione S-transferase placental form positive foci in liver and epithelial hyperplasia in urinary bladder, but no tumor development in male Fischer 344 rats treated with monomethylarsonic acid for 104 weeks. , 2003, Toxicology and applied pharmacology.

[3]  S. Fukushima,et al.  Liver tumorigenicity of trimethylarsine oxide in male Fischer 344 rats--association with oxidative DNA damage and enhanced cell proliferation. , 2003, Carcinogenesis.

[4]  S. Okada,et al.  Oxidative DNA damage following exposure to dimethylarsinous iodide: the formation of cis-thymine glycol. , 2003, Toxicology letters.

[5]  S. Fukushima,et al.  Carcinogenicity of dimethylarsinic acid in p53 heterozygous knockout and wild-type C57BL/6J mice. , 2003, Carcinogenesis.

[6]  K. Kitchin,et al.  Oxidative stress as a possible mode of action for arsenic carcinogenesis. , 2003, Toxicology letters.

[7]  J. Ward,et al.  Transplacental carcinogenicity of inorganic arsenic in the drinking water: induction of hepatic, ovarian, pulmonary, and adrenal tumors in mice. , 2003, Toxicology and applied pharmacology.

[8]  S. Fukushima,et al.  Carcinogenicity of dimethylarsinic acid in male F344 rats and genetic alterations in induced urinary bladder tumors. , 2002, Carcinogenesis.

[9]  S. Fukushima,et al.  Promoting effects of monomethylarsonic acid, dimethylarsinic acid and trimethylarsine oxide on induction of rat liver preneoplastic glutathione S‐transferase placental form positive foci: A possible reactive oxygen species mechanism , 2002, International journal of cancer.

[10]  Michael F Hughes,et al.  Arsenic toxicity and potential mechanisms of action. , 2002, Toxicology letters.

[11]  W. Cullen,et al.  Plasmid DNA damage caused by methylated arsenicals, ascorbic acid and human liver ferritin. , 2002, Toxicology letters.

[12]  S. Fukushima,et al.  Lack of promoting effect due to oral administration of dimethylarsinic acid on rat lung carcinogenesis initiated with N-bis(2-hydroxypropyl)nitrosamine. , 2002, Cancer letters.

[13]  M. Vahter,et al.  Role of metabolism in arsenic toxicity. , 2001, Pharmacology & toxicology.

[14]  K. Kitchin.  Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites. , 2001, Toxicology and applied pharmacology.

[15]  E. Kenyon,et al.  A concise review of the toxicity and carcinogenicity of dimethylarsinic acid. , 2001, Toxicology.

[16]  W. Cullen,et al.  Methylated trivalent arsenic species are genotoxic. , 2001, Chemical research in toxicology.

[17]  S. X. Liu,et al.  Induction of oxyradicals by arsenic: implication for mechanism of genotoxicity. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[18]  W. Cullen,et al.  Arsenic species that cause release of iron from ferritin and generation of activated oxygen. , 2000, Archives of biochemistry and biophysics.

[19]  J. Sawicki,et al.  K6/ODC transgenic mice as a sensitive model for carcinogen identification. , 2000, Toxicology letters.

[20]  D. Morgan,et al.  Occurrence of monomethylarsonous acid in urine of humans exposed to inorganic arsenic. , 2000, Chemical research in toxicology.

[21]  S. Fukushima,et al.  Promotion of Skin Carcinogenesis by Dimethylarsinic Acid in Keratin (K6)/ODC Transgenic Mice , 2000, Japanese journal of cancer research : Gann.

[22]  Wei Li,et al.  Urinary bladder carcinogenicity of dimethylarsinic acid in male F344 rats. , 1999, Carcinogenesis.

[23]  Wei Li,et al.  Promotion of NCI-Black-Reiter male rat bladder carcinogenesis by dimethylarsinic acid an organic arsenic compound. , 1998, Cancer letters.

[24]  S. X. Liu,et al.  Mutagenicity of arsenic in mammalian cells: role of reactive oxygen species. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[25]  S. Okada,et al.  Dimethylarsinic acid, a main metabolite of inorganic arsenics, has tumorigenicity and progression effects in the pulmonary tumors of A/J mice. , 1998, Cancer letters.

[26]  G. Endo,et al.  Aneuploidy induced by dimethylarsinic acid in mouse bone marrow cells. , 1998, Mutation research.

[27]  S. Fukushima,et al.  Promotion of Rat Hepatocarcinogenesis by Dimethylarsinic Acid: Association with Elevated Ornithine Decarboxylase Activity and Formation of 8‐Hydroxydeoxyguanosine in the Liver , 1997, Japanese journal of cancer research : Gann.

[28]  H. Aposhian,et al.  Enzymatic methylation of arsenic compounds: IV. In vitro and in vivo deficiency of the methylation of arsenite and monomethylarsonic acid in the guinea pig. , 1997, Mutation research.

[29]  Y. Hsueh,et al.  Arsenic methylation capacity, body retention, and null genotypes of glutathione S-transferase M1 and T1 among current arsenic-exposed residents in Taiwan. , 1997, Mutation research.

[30]  K. Harrington-Brock,et al.  Relative genotoxic potency of arsenic and its methylated metabolites. , 1997, Mutation research.

[31]  G. Endo,et al.  Metabolites of Arsenic Induced Tetraploids and Mitotic Arrest in Cultured Cells , 1997, Archives of environmental contamination and toxicology.

[32]  H. Aposhian.  Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity. , 1997, Annual review of pharmacology and toxicology.

[33]  S. Fukushima,et al.  Promoting effects of dimethylarsinic acid on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in rats. , 1996, Carcinogenesis.

[34]  T. Kaise,et al.  Induction of chromosomal aberrations in cultured human fibroblasts by inorganic and organic arsenic compounds and the different roles of glutathione in such induction. , 1996, Mutation research.

[35]  S. Fukushima,et al.  Cancer induction by an organic arsenic compound, dimethylarsinic acid (cacodylic acid), in F344/DuCrj rats after pretreatment with five carcinogens. , 1995, Cancer research.

[36]  M. Vahter.  Species differences in the metabolism of arsenic compounds , 1994 .

[37]  T. S. Wang,et al.  Active oxygen species are involved in the induction of micronuclei by arsenite in XRS-5 cells. , 1994, Mutagenesis.

[38]  U. Thorgeirsson,et al.  Tumor incidence in a chemical carcinogenesis study of nonhuman primates. , 1994, Regulatory toxicology and pharmacology : RTP.

[39]  S. Horiguchi,et al.  Dimethylarsenic acid induces tetraploids in Chinese hamster cells , 1992, Bulletin of environmental contamination and toxicology.

[40]  S. Okada,et al.  Cellular response to oxidative damage in lung induced by the administration of dimethylarsinic acid, a major metabolite of inorganic arsenics, in mice. , 1991, Toxicology and applied pharmacology.

[41]  S. Okada,et al.  Induction of DNA damage by dimethylarsine, a metabolite of inorganic arsenics, is for the major part likely due to its peroxyl radical. , 1990, Biochemical and biophysical research communications.

[42]  S. Okada,et al.  Mutagenicity of dimethylated metabolites of inorganic arsenics. , 1989, Chemical & pharmaceutical bulletin.

[43]  D. Bleyl,et al.  IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs vol. 1 to 42. Supplement 7. 440 Seiten. International Agency for Research on Cancer, Lyon 1987. Preis: 65, – s.Fr , 1989 .

[44]  M. Vahter,et al.  Biotransformation of trivalent and pentavalent inorganic arsenic in mice and rats. , 1981, Environmental research.

[45]  J. Brouwer,et al.  Pathologic changes in rats and dogs from two-year feeding of sodium arsenite or sodium arsenate. , 1967, Toxicology and applied pharmacology.